Kyverna Therapeutics, Inc.
General ticker "KYTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $163.6M (TTM average)
Kyverna Therapeutics, Inc. follows the US Stock Market performance with the rate: 57.0%.
Estimated limits based on current volatility of 3.8%: low 7.86$, high 8.48$
Factors to consider:
- Total employees count: 96 as of 2023
Short-term KYTX quotes
Long-term KYTX plot
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $142.60MM |
| Operating Income | $-142.60MM |
| Non-Operating Income | $15.13MM |
| Interest Expense | $0.14MM |
| R&D Expense | $112.47MM |
| Income(Loss) | $-127.48MM |
| Profit(Loss)* | $-127.48MM |
| Stockholders Equity | $266.59MM |
| Assets | $304.64MM |
| Operating Cash Flow | $-114.25MM |
| Capital expenditure | $2.21MM |
| Investing Cash Flow | $-160.90MM |
| Financing Cash Flow | $337.11MM |
| Earnings Per Share** | $-3.33 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.